Bausch & Lomb sets its sights on a 2012 IPO
Eye care giant Bausch & Lomb may return to public markets before the end of this year, according to people familiar with the company.
Eye care goliath Bausch & Lomb may be looking to go public this year, a move that would signal renewed confidence in the company following a bit of a rough patch.
Bausch was taken private in 2007 by Warburg Pincus for $4.5 billion after accounting discrepancies forced the company to restate its earnings and contaminated contact disinfectant solution resulted in a high-profile recall.
The company has been on the path to improved valuation, padding its portfolio with acquisitions in advance of a long-term plan to return to public markets, according to the Wall Street Journal, which cited "people familiar with the company."